Format

Send to

Choose Destination
Clin Chest Med. 2002 Sep;23(3):613-21, vi.

Management of disease due to Mycobacterium kansasii.

Author information

1
Department of Medicine, University of Texas Health Center, 11937 US Highway 271, Tyler, TX 75708-3154, USA. david.griffith@uthct.edu

Abstract

Mycobacterium kansasii presents clinically in a manner most resembling tuberculosis. Diagnosis is usually not difficult; however, the significance of M kansasii isolates from some patients may be hard to determine. Usually, the presence of even one respiratory culture positive for M kansasii is sufficient to make a diagnosis, though few patients can have single respiratory culture positive for M kansasii without evidence of active disease. If not started on medication, these patients must be followed closely. Effective treatment can usually be accomplished with a rifampin-based regimen, or a rifabutin-based regimen for HIV-seropositive patients receiving antiretroviral therapy. Short course and intermittent regimens for treating M kansaii disease show promise but are not yet recommended for routine use.

PMID:
12370997
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center